Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Lohse

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Archives of Disease in Childhood|August 22, 2024
Diagnosis journey for children with juvenile idiopathic arthritis: a qualitative studyAurelie Chausset, Caroline Freychet, Anne Lohse, et al.
Joint Bone Spine|March 11, 2008
Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapyDaniel Wendling, Jean-Charles Balblanc, Daniel Briançon, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional studyAnne Lohse, Marie Bossert, Ana-Maria Bozgan, et al.
Joint Bone Spine|July 26, 2005
Infliximab continuation rates in patients with rheumatoid arthritis in everyday practiceDaniel Wendling, Guewen-Edouard Materne, Fabrice Michel, et al.
Joint Bone Spine|February 23, 2010
Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practiceEric Toussirot, Edouard Pertuiset, Christelle Sordet, et al.
The Journal of Rheumatology|October 3, 2009
Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case seriesEric Toussirot, Jean Marie Berthelot, Edouard Pertuiset, et al.
Frontiers in Immunology|July 13, 2023
ATHLETIQUE: interest of an adapted physical activity program in patients with juvenile idiopathic arthritis: a feasibility and preliminary effectiveness studyStéphanie Py, Florine Maylié, Anne-Laure Parmentier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Frontiers in Medicine|December 6, 2021
Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to SchoolBaptiste Quéré, Irene Lemelle, Anne Lohse, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Archives of Disease in Childhood|August 22, 2024
Diagnosis journey for children with juvenile idiopathic arthritis: a qualitative studyAurelie Chausset, Caroline Freychet, Anne Lohse, et al.
Joint Bone Spine|March 11, 2008
Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapyDaniel Wendling, Jean-Charles Balblanc, Daniel Briançon, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional studyAnne Lohse, Marie Bossert, Ana-Maria Bozgan, et al.
Joint Bone Spine|July 26, 2005
Infliximab continuation rates in patients with rheumatoid arthritis in everyday practiceDaniel Wendling, Guewen-Edouard Materne, Fabrice Michel, et al.
Joint Bone Spine|February 23, 2010
Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practiceEric Toussirot, Edouard Pertuiset, Christelle Sordet, et al.
The Journal of Rheumatology|October 3, 2009
Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case seriesEric Toussirot, Jean Marie Berthelot, Edouard Pertuiset, et al.
Frontiers in Immunology|July 13, 2023
ATHLETIQUE: interest of an adapted physical activity program in patients with juvenile idiopathic arthritis: a feasibility and preliminary effectiveness studyStéphanie Py, Florine Maylié, Anne-Laure Parmentier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Frontiers in Medicine|December 6, 2021
Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to SchoolBaptiste Quéré, Irene Lemelle, Anne Lohse, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Pageof 4